Article List

WPRIM Management System> DCMS> Gut and Liver> 2018> 12> 2

Volume: 12 Issue: 2

1. Post-ERCP Bleeding in the Era of Multiple Antiplatelet Agents.	Page:214—218
2. Groove Pancreatitis: Endoscopic Treatment via the Minor Papilla and Duct of Santorini Morphology.	Page:208—213
3. Rapid Changes in Serum Lipid Profiles during Combination Therapy with Daclatasvir and Asunaprevir in Patients Infected with Hepatitis C Virus Genotype 1b.	Page:201—207
4. Combination of Transient Elastography and an Enhanced Liver Fibrosis Test to Assess the Degree of Liver Fibrosis in Patients with Chronic Hepatitis B.	Page:190—200
5. Quality Metrics of a Fecal Immunochemical Test-Based Colorectal Cancer Screening Program in Korea.	Page:183—189
6. Methylation Status of Transcriptional Modulatory Genes Associated with Colorectal Cancer in Northeast China.	Page:173—182
7. Clinical Outcomes of Standard Triple Therapy Plus Probiotics or Concomitant Therapy for Helicobacter pylori Infection.	Page:165—172
8. Associations among Gastric Juice pH, Atrophic Gastritis, Intestinal Metaplasia and Helicobacter pylori Infection.	Page:158—164
9. Efficacy of a Three-Dimensional-Printed Training Simulator for Endoscopic Biopsy in the Stomach.	Page:149—157
10. Fecal Immunochemical Test and Fecal Calprotectin Results Show Different Profiles in Disease Monitoring for Ulcerative Colitis.	Page:142—148
11. Long-Term Effects of Helicobacter pylori Eradication on Metachronous Gastric Cancer Development.	Page:133—141
12. Diverticular Disease: An Update on Pathogenesis and Management.	Page:125—132
13. Long-Term Outcomes of Using Endoscopic Submucosal Dissection to Treat Early Gastric Cancer.	Page:119—124
14. Fecal Immunochemical Test and Fecal Calprotectin Measurement Are Noninvasive Monitoring Tools for Predicting Endoscopic Activity in Patients with Ulcerative Colitis.	Page:117—118
15. Exploring the Link between Helicobacter pylori Eradication and Metachronous Gastric Cancer Development.	Page:115—116